Interleukin-21 variants with altered binding to the IL-21 receptor
US8211420B2 · kind B2 · utility
23Cited by
13References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2007 |
| Grant date | Jul 3, 2012 |
| Priority date | — |
| Expiry date | Dec 20, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is concerned with IL-21 polypeptide variants having an altered binding to the common gamma chain (c) of the IL-21 receptor and the use thereof in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.